Petr Horák1, Nicholas Gibbons2, Juraj Sýkora3,4, Aida Batista5, Jonathan Underhill2. 1. University Hospital Motol, Hospital Pharmacy, Prague, Czech Republic. 2. Keele University, Centre for Medicines Optimisation School of Pharmacy Keele, Keele, UK. 3. Slovak Health University, Pharmacy Institute Bratislava, Bratislava, Slovakia. 4. Department of Pharmacy, National Cancer Institute, Bratislava, Slovakia. 5. Hospital Pharmacy, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.
Abstract
BACKGROUND: The 2016 European Association of Hospital Pharmacists (EAHP) Statements survey builds on previous surveys and focuses on sections 1, 3 and 4. OBJECTIVE: To collect statistical data about the level of implementation of the Statements, and identify important barriers to their implementation. METHODS: An online questionnaire was sent to all hospital pharmacies in EAHP member countries. Data were analysed by researchers from Keele University School of Pharmacy, UK and the EAHP Survey Group. If an incomplete survey was submitted, the quantitative data were not used, although any free-text responses were incorporated. RESULTS: The overall response rate was 16% (904 out of 5711 requests) with 730 complete responses. In the first part of the survey, data were collected on the hospital pharmacy setting. While almost half (n=335) of hospital pharmacies served over 500 beds, 77% (n=564) of hospital pharmacies had ≤10 pharmacists. In section B, evidence was gathered about the degree of implementation of sections 1, 3 and 4 of the Statements and the main barriers to, and drivers of, implementation. The questions related to production and compounding (section 3) received very positive responses (all questions from this section received at least a 70% positive response rate), indicating that responders are having less difficulty implementing these statements compared with others. The introductory statements and governance questions (section 1) received a more mixed response. Only 343 (47%) responses indicated that the pharmacists worked routinely as part of multidisciplinary team. Many of the questions relating to clinical pharmacy services (section 4) received a more negative response overall, with six questions receiving <50% positive responses. CONCLUSIONS: This iteration of the survey provides the EAHP with further insight into the implementation of the Statements across the member countries as well as the barriers to, and drivers of, implementation in sections 1, 3 and 4. This is essential to inform the plans for EAHP to best support their implementation.
BACKGROUND: The 2016 European Association of Hospital Pharmacists (EAHP) Statements survey builds on previous surveys and focuses on sections 1, 3 and 4. OBJECTIVE: To collect statistical data about the level of implementation of the Statements, and identify important barriers to their implementation. METHODS: An online questionnaire was sent to all hospital pharmacies in EAHP member countries. Data were analysed by researchers from Keele University School of Pharmacy, UK and the EAHP Survey Group. If an incomplete survey was submitted, the quantitative data were not used, although any free-text responses were incorporated. RESULTS: The overall response rate was 16% (904 out of 5711 requests) with 730 complete responses. In the first part of the survey, data were collected on the hospital pharmacy setting. While almost half (n=335) of hospital pharmacies served over 500 beds, 77% (n=564) of hospital pharmacies had ≤10 pharmacists. In section B, evidence was gathered about the degree of implementation of sections 1, 3 and 4 of the Statements and the main barriers to, and drivers of, implementation. The questions related to production and compounding (section 3) received very positive responses (all questions from this section received at least a 70% positive response rate), indicating that responders are having less difficulty implementing these statements compared with others. The introductory statements and governance questions (section 1) received a more mixed response. Only 343 (47%) responses indicated that the pharmacists worked routinely as part of multidisciplinary team. Many of the questions relating to clinical pharmacy services (section 4) received a more negative response overall, with six questions receiving <50% positive responses. CONCLUSIONS: This iteration of the survey provides the EAHP with further insight into the implementation of the Statements across the member countries as well as the barriers to, and drivers of, implementation in sections 1, 3 and 4. This is essential to inform the plans for EAHP to best support their implementation.
Entities:
Keywords:
EAHP; European Statements of Hospital Pharmacy; Healthcare Survey; Hospitals; hospital pharmacy services
Authors: Ruomeng Yang; Qian Li; Khezar Hayat; Panpan Zhai; Wenchen Liu; Chen Chen; Amna Saeed; Jie Chang; Pengchao Li; Qianqian Du; Sen Xu; Jun Wen; Yu Fang Journal: Front Public Health Date: 2022-06-15